Study suggests breast cancer survivors may not need lifelong heart medication

A recent trial indicates that most breast cancer survivors whose treatment has resulted in heart problems may not require lifelong medication. The study, funded by the British Heart Foundation, involved 90 women across four hospitals whose hearts had recovered after specific breast cancer treatments. Most participants were in their 40s and 50s and had previously been advised to continue heart medications for life due to potential declines in heart function. However, the researchers found that 98% of those who discontinued medication showed no change in heart function after one year, with only one participant experiencing a decline in heart pumping ability. Additionally, women who stopped taking heart drugs reported an improved quality of life. Professor Charlotte Manisty, head of clinical cardiovascular science at University College London and lead author of the study published in the Heart Journal, stated that the findings provide evidence that heart failure therapies can be safely discontinued in survivors whose hearts have recovered, with appropriate monitoring. Lucy Shepherd, a participant diagnosed with breast cancer at age 33, shared her positive experience in the trial, noting that it helped her regain trust in her body. The women involved in the study will be monitored for their heart health over the next five years. Dr. Sonya Babu-Narayan from the British Heart Foundation emphasized the encouraging nature of the findings for breast cancer survivors, while also noting the need for further research.